PTJ
AGN

Paul Tudor Jones’s Allergan plc AGN Stock Holding History

Paul Tudor Jones’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-500,000
Closed -$88.5M – 1525
2020
Q1 		$88.5M Buy
+500,000
New +$94.1M 7.93% 2
2016
Q2 		– Sell
-140,000
Closed -$37.5M – 2042
2016
Q1 		$37.5M Buy
140,000
+120,000
+600% +$34.4M 0.96% 13
2015
Q4 		$6.25M Buy
+20,000
New +$5.95M 0.18% 89

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Paul Tudor Jones's AGN Position: Q2 2020 in Review

Paul Tudor Jones sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 619,565 shares — an estimated $110M sold.

Paul Tudor Jones first reported a position in AGN in Q2 2013 and held it in 26 quarters. The position peaked at $119M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Paul Tudor Jones reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Paul Tudor Jones sold 619,565 Allergan plc shares in Q2 2020, an estimated $110M.
  • Paul Tudor Jones first reported a position in Allergan plc in Q2 2013 and held it in 26 quarters.
  • Paul Tudor Jones's Allergan plc position peaked at $119M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Tudor Investment Corp's 13F filing for Q2 2020, filed 14 Aug 2020.